Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (23928)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 28, 2017 (publication date) through May 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Radiology
ISSN
1949-8470
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kay FU, Kandathil A, Batra K, Saboo SS, Abbara S, Rajiah P. Revisions to the Tumor, Node, Metastasis staging of lung cancer (8th edition): Rationale, radiologic findings and clinical implications. World J Radiol 2017; 9(6): 269-279 [PMID: 28717413 DOI: 10.4329/wjr.v9.i6.269] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8470/full/v9/i6/269.htm |
| Number | Citing Articles |
| 1 |
Yue‑Hua Zhang, Yuquan Lu, Hong Lu, Meng‑Wei Zhang, Yue‑Min Zhou, Xiang‑Lei Li, Pin Lv, Xiao‑Yan Zhao. Pre‑treatment hemoglobin levels are an independent prognostic factor in patients with non‑small cell lung cancer. Molecular and Clinical Oncology 2018; doi: 10.3892/mco.2018.1628
|
| 2 |
Qiuyuan Hu, Ke Li, Conghui Yang, Yue Wang, Rong Huang, Mingqiu Gu, Yuqiang Xiao, Yunchao Huang, Long Chen. The role of artificial intelligence based on PET/CT radiomics in NSCLC: Disease management, opportunities, and challenges. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1133164
|
| 3 |
Iain McPherson, Nicholas A. Bradley, Rohith Govindraj, Ewan D. Kennedy, Alan J.B. Kirk, Mohammed Asif. The progression of non-small cell lung cancer from diagnosis to surgery. European Journal of Surgical Oncology 2020; 46(10): 1882 doi: 10.1016/j.ejso.2020.08.013
|
| 4 |
Xue-qian Wang, Ying Zhang, Wei Hou, Ying-tian Wang, Jia-bin Zheng, Jie Li, Li-zhu Lin, Yi-lan Jiang, Shen-yu Wang, Ying Xie, Hong-liang Zhang, Qi-jin Shu, Ping Li, Wei Wang, Jian-liang You, Ge Li, Jie Liu, Hui-ting Fan, Mei-ying Zhang, Hong-sheng Lin. Association between Chinese Medicine Therapy and Survival Outcomes in Postoperative Patients with NSCLC: A Multicenter, Prospective, Cohort Study. Chinese Journal of Integrative Medicine 2019; 25(11): 812 doi: 10.1007/s11655-019-3168-6
|
| 5 |
Niral M. Patel, Ali I. Musani. Photodynamic Therapy - From Basic Science to Clinical Research. 2021; doi: 10.5772/intechopen.95473
|
| 6 |
Hatsuyo Takaoka, Hideki Terai, Katsura Emoto, Lisa Shigematsu, Fumimaro Ito, Ayaka Saito, Masahiko Okada, Keiko Ohgino, Shinnosuke Ikemura, Hiroyuki Yasuda, Ichiro Nakachi, Ichiro Kawada, Koichi Fukunaga, Kenzo Soejima. Long-Term Treatment-Free Survival After Multimodal Therapy in a Patient with Stage IV Lung Adenocarcinoma. OncoTargets and Therapy 2022; : 981 doi: 10.2147/OTT.S375959
|
| 7 |
Kellie J. Ryan, Karen E. Skinner, Ancilla W. Fernandes, Rajeshwari S. Punekar, Melissa Pavilack, Mark S. Walker, Noam A. VanderWalde. Real-world outcomes in patients with unresected stage III non-small cell lung cancer. Medical Oncology 2019; 36(3) doi: 10.1007/s12032-019-1249-1
|
| 8 |
Asha Kandathil, Robert Carson Sibley III, Rathan M. Subramaniam. Lung Cancer Recurrence: 18F-FDG PET/CT in Clinical Practice. American Journal of Roentgenology 2019; 213(5): 1136 doi: 10.2214/AJR.19.21227
|
| 9 |
Chaima Khadhraoui, Wajih Kaabachi, Fatma Tritar, Hafaoua Daghfous, Kamel Hamzaoui, Agnes Hamzaoui. Association of BTLA rs1982809 polymorphism with lung cancer risk in Tunisian population. International Journal of Immunogenetics 2020; 47(6): 554 doi: 10.1111/iji.12491
|
| 10 |
Francesca Colonese, Stefania Canova, Francesco Petrella, Diego Luigi Cortinovis. Oligometastatic Disease in Lung Cancer for Surgeons: An Update. Current Surgery Reports 2018; 6(3) doi: 10.1007/s40137-018-0203-z
|
| 11 |
Pengrong Lou, Shitao Zou, Zengfu Shang, Chao He, Aidi Gao, Shunyu Hou, Jundong Zhou. RAD18 contributes to the migration and invasion of human cervical cancer cells via the interleukin‑1β pathway. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10564
|
| 12 |
Chae Hong Lim, Tae Ran Ahn, Seung Hwan Moon, Young Seok Cho, Joon Young Choi, Byung-Tae Kim, Kyung-Han Lee. PET/CT features discriminate risk of metastasis among single-bone FDG lesions detected in newly diagnosed non-small-cell lung cancer patients. European Radiology 2019; 29(4): 1903 doi: 10.1007/s00330-018-5764-9
|
| 13 |
Maha Esmeal Ahmed, Mwahib Sid Ahmed Aldosh. IMAGING OF LUNG CANCER STAGING USING ADVANCED CT SCAN TECHNIQUES. International Journal of Research -GRANTHAALAYAH 2020; 8(3): 22 doi: 10.29121/granthaalayah.v8.i3.2020.120
|
| 14 |
Jiuling Cheng, Lujia Zhou, Huaqi Wang. Symbiotic microbial communities in various locations of the lung cancer respiratory tract along with potential host immunological processes affected. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1296295
|
| 15 |
Jana S. Hopstaken, Julianne C. de Ruiter, Ronald A.M. Damhuis, Adrianus J. de Langen, Judi N.A. van Diessen, Houke M. Klomp, Elisabeth G. Klompenhouwer, Koen J. Hartemink. Stage I non-small cell lung cancer: Treatment modalities, Dutch daily practice and future perspectives. Cancer Treatment and Research Communications 2021; 28: 100404 doi: 10.1016/j.ctarc.2021.100404
|
| 16 |
Meng Dai, Na Wang, Xinming Zhao, Jianyuan Zhang, Zhaoqi Zhang, Jingmian Zhang, Jianfang Wang, Yujing Hu, Yunuan Liu, Xiujuan Zhao, Xiaolin Chen. Value of Presurgical 18F-FDG PET/CT Radiomics for Predicting Mediastinal Lymph Node Metastasis in Patients with Lung Adenocarcinoma. Cancer Biotherapy and Radiopharmaceuticals 2022; doi: 10.1089/cbr.2022.0038
|
| 17 |
Yu-Yao Shen, Jing Jiang, Jing Zhao, Jie Song. Lung squamous cell carcinoma presenting as rare clustered cystic lesions: A case report and review of literature. World Journal of Clinical Cases 2022; 10(35): 13006-13014 doi: 10.12998/wjcc.v10.i35.13006
Abstract(335) |
Core Tip(161) |
Full Article(HTML)(1195)
|
Full Article (PDF)-9353K(104)
|
Full Article (Word)-1803K(26)
|
Audio-1075K(0)
|
Peer-Review Report-359K(26)
|
Answering Reviewers-150K(33)
|
Times Cited (0)
|
Total Visits (3572)
|
Open
|
| 18 |
Quanfu Yang. MicroRNA-5195-3p plays a suppressive role in cell proliferation, migration and invasion by targeting MYO6 in human non-small cell lung cancer. Bioscience, Biotechnology, and Biochemistry 2019; 83(2): 212 doi: 10.1080/09168451.2018.1540288
|
| 19 |
增燕 马. Analysis of Clinical Characteristics of Advanced Lung Adenocarcinoma with Pulmonary Embolism and Predictive Value of D-Dimer. Advances in Clinical Medicine 2024; 14(04): 663 doi: 10.12677/acm.2024.1441074
|
| 20 |
Asha Kandathil, Fernando U. Kay, Yasmeen M. Butt, Jason W. Wachsmann, Rathan M. Subramaniam. Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non–Small Cell Lung Cancer. RadioGraphics 2018; 38(7): 2134 doi: 10.1148/rg.2018180060
|
| 21 |
Bingqing Long, Zeng Xiong, Manzo Habou. Lung cancer screening, diagnosis, and treatment: The radiologist's perspective. Meta-Radiology 2024; 2(1): 100066 doi: 10.1016/j.metrad.2024.100066
|
| 22 |
M Patricia Rivera. Updates in Lung Cancer 2018—What the Pulmonologist Needs to Know. Oncology & Hematology Review (US) 2019; 15(1): 20 doi: 10.17925/OHR.2019.15.1.20
|
| 23 |
Bryan C. Husta, Or Kalchiem-Dekel, Jason A. Beattie, Kazuhiro Yasufuku. Mediastinal Staging with Endobronchial Ultrasound in Early-Stage Non—Small Cell Lung Cancer: Is It Necessary?. Seminars in Respiratory and Critical Care Medicine 2022; 43(04): 503 doi: 10.1055/s-0042-1748189
|
| 24 |
Sanaz Katal, Thomas G. Clifford, Kanhaiyalal Agrawal, Ali Gholamrezanezhad. Radiology‐Nuclear Medicine Diagnostic Imaging. 2023; : 333 doi: 10.1002/9781119603627.ch11
|
| 25 |
Iago Dillion Lima Cavalcanti. Chemotherapy Protocols and Infusion Sequence. 2022; : 291 doi: 10.1007/978-3-031-10839-6_9
|
| 26 |
Soo Bin Park, Ki-Up Kim, Young Woo Park, Jung Hwa Hwang, Chae Hong Lim. Application of 18F-fluorodeoxyglucose PET/CT radiomic features and machine learning to predict early recurrence of non-small cell lung cancer after curative-intent therapy. Nuclear Medicine Communications 2023; 44(2): 161 doi: 10.1097/MNM.0000000000001646
|
| 27 |
Chae Hong Lim, Soo Bin Park, Hong Kwan Kim, Yong Soo Choi, Jhingook Kim, Yong Chan Ahn, Myung-ju Ahn, Joon Young Choi. Clinical Value of Surveillance 18F-fluorodeoxyglucose PET/CT for Detecting Unsuspected Recurrence or Second Primary Cancer in Non-Small Cell Lung Cancer after Curative Therapy. Cancers 2022; 14(3): 632 doi: 10.3390/cancers14030632
|
| 28 |
Astridur Petursdottir, Johanna Sigurdardottir, Bjorn M. Fridriksson, Arni Johnsen, Helgi J. Isaksson, Hronn Hardardottir, Steinn Jonsson, Tomas Gudbjartsson. Pulmonary carcinoid tumours: incidence, histology, and surgical outcome. A population-based study. General Thoracic and Cardiovascular Surgery 2020; 68(5): 523 doi: 10.1007/s11748-019-01261-w
|
| 29 |
Jingjing Fu, Yan Xie, Tong Fu, Fan Qiu, Fei Yu, Wei Qu, Xiaochen Yao, Aiping Zhang, Zhenhua Yang, Guoqiang Shao, Qingle Meng, Xiumin Shi, Yue Huang, Wei Gu, Feng Wang. [99mTc]Tc-Galacto-RGD2 integrin αvβ3-targeted imaging as a surrogate for molecular phenotyping in lung cancer: real-world data. EJNMMI Research 2021; 11(1) doi: 10.1186/s13550-021-00801-x
|
| 30 |
Niels Lyhne Christensen, Anne Mette Tranberg Kejs, Erik Jakobsen, Susanne Oksbjerg Dalton, Torben Riis Rasmussen. Early death in Danish stage I lung cancer patients: a population-based case study. Acta Oncologica 2018; 57(11): 1561 doi: 10.1080/0284186X.2018.1497298
|
| 31 |
Jingwen Wei, Jing Xiang, Yue Hao, Jinfei Si, Wenxian Wang, Fangyin Li, Zhengbo Song. Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study. BMC Pulmonary Medicine 2022; 22(1) doi: 10.1186/s12890-022-02158-w
|
| 32 |
Anna Rita Larici, Giuseppe Cicchetti, Roberto Iezzi, Lucio Calandriello, Andrea Contegiacomo, Alessandro Posa, Silvia Taralli, Elizabeth K. A. Triumbari, Maria Lucia Calcagni, Alessandro Giordano, Riccardo Manfredi, Cesare Colosimo. Multimodality Imaging and Intervention in Oncology. 2023; : 107 doi: 10.1007/978-3-031-28524-0_7
|
| 33 |
Yujiao Xie, Yi Zhang, Lutao Du, Xiumei Jiang, Suzhen Yan, Weili Duan, Juan Li, Yao Zhan, Lili Wang, Shujun Zhang, Shuhai Li, Lishui Wang, Shuo Xu, Chuanxin Wang. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non‐small cell lung cancer. Molecular Oncology 2018; 12(5): 648 doi: 10.1002/1878-0261.12188
|
| 34 |
Pei-Fang Hung, Tse-Ming Hong, Che-Chang Chang, Chung-Lieh Hung, Yuan-Ling Hsu, Yih-Leong Chang, Chen-Tu Wu, Gee-Chen Chang, Nei-Li Chan, Sung-Liang Yu, Pan-Chyr Yang, Szu-Hua Pan. Hypoxia-induced Slug SUMOylation enhances lung cancer metastasis. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-018-0996-8
|
| 35 |
Yan Wang, Jialong Li, Shuai Chang, Yingxian Dong, Guowei Che. Prognostic Characteristics of Operated Breast Cancer Patients with Second Primary Lung Cancer: A Retrospective Study. Cancer Management and Research 2021; : 5309 doi: 10.2147/CMAR.S312419
|
| 36 |
Nevin Aydin, Elif Gundogdu. Evaluation of the relationship of the T and M stage with the erector spinae muscle area in male lung cancer patients. The Aging Male 2023; 26(1) doi: 10.1080/13685538.2022.2154336
|
| 37 |
Alessandra Ferro, Matteo Sepulcri, Marco Schiavon, Elena Scagliori, Edoardo Mancin, Francesca Lunardi, Gisella Gennaro, Stefano Frega, Alessandro Dal Maso, Laura Bonanno, Chiara Paronetto, Francesca Caumo, Fiorella Calabrese, Federico Rea, Valentina Guarneri, Giulia Pasello. The Multidisciplinary Approach in Stage III Non-Small Cell Lung Cancer over Ten Years: From Radiation Therapy Optimisation to Innovative Systemic Treatments. Cancers 2022; 14(22): 5700 doi: 10.3390/cancers14225700
|
| 38 |
Salma Dammak, Stephanie Gulstene, David A. Palma, Sarah A. Mattonen, Suresh Senan, Aaron D. Ward. Distinguishing recurrence from radiation-induced lung injury at the time of RECIST progressive disease on post-SABR CT scans using radiomics. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-52828-4
|
| 39 |
Brandilyn A. Peters, Harvey I. Pass, Robert D. Burk, Xiaonan Xue, Chandra Goparaju, Christopher C. Sollecito, Evan Grassi, Leopoldo N. Segal, Jun-Chieh J. Tsay, Richard B. Hayes, Jiyoung Ahn. The lung microbiome, peripheral gene expression, and recurrence-free survival after resection of stage II non-small cell lung cancer. Genome Medicine 2022; 14(1) doi: 10.1186/s13073-022-01126-7
|
| 40 |
Parth Patel, Raja Flores, Naomi Alpert, Bruce Pyenson, Emanuela Taioli. Effect of stage shift and immunotherapy treatment on lung cancer survival outcomes. European Journal of Cardio-Thoracic Surgery 2023; 64(2) doi: 10.1093/ejcts/ezad203
|
| 41 |
Kexin Huang, Lifeng Yang, Yubo Wang, Liyu Huang, Xiaobo Zhou, Wei Zhang. Identification of non-small-cell lung cancer subtypes by unsupervised clustering of CT image features with distinct prognoses and gene pathway activities. Biomedical Signal Processing and Control 2022; 76: 103643 doi: 10.1016/j.bspc.2022.103643
|
| 42 |
G.K. Gedik, F. Yilmaz. ¿Hay alguna mejora en la estadificación clínica con PET/TC con 18F-FDG en comparación con la estadificación quirúrgica en el cáncer de pulmón?. Revista Española de Medicina Nuclear e Imagen Molecular 2019; 38(6): 348 doi: 10.1016/j.remn.2019.05.005
|
| 43 |
Manuel Garcia-Algar, Ana Fernandez-Carrascal, Ana Olano-Daza, Luca Guerrini, Neus Feliu, Wolfgang J. Parak, Roger Guimera, Eduardo Garcia-Rico, Ramon A. Alvarez-Puebla. Adaptive metabolic pattern biomarker for disease monitoring and staging of lung cancer with liquid biopsy. npj Precision Oncology 2018; 2(1) doi: 10.1038/s41698-018-0059-9
|
| 44 |
Wouter A. C. van Amsterdam, Netanja I. Harlianto, Joost J. C. Verhoeff, Pim Moeskops, Pim A. de Jong, Tim Leiner. The Association between Muscle Quantity and Overall Survival Depends on Muscle Radiodensity: A Cohort Study in Non-Small-Cell Lung Cancer Patients. Journal of Personalized Medicine 2022; 12(7): 1191 doi: 10.3390/jpm12071191
|
| 45 |
Emanuele Voulaz, Pierluigi Novellis, Francesca Rossetti, Michela Solinas, Sabrina Rossi, Marco Alloisio, Giuseppe Pelosi, Giulia Veronesi. Distinguishing multiple lung primaries from intra-pulmonary metastases and treatment implications. Expert Review of Anticancer Therapy 2020; 20(11): 985 doi: 10.1080/14737140.2020.1823223
|
| 46 |
Alihan SUİÇMEZ, Çağrı SUİÇMEZ, Cengiz TEPE. LUNG CANCER DETECTION BY HYBRID LEARNING METHOD APPLYING SMOTE TECHNIQUE. Gazi Üniversitesi Fen Bilimleri Dergisi Part C: Tasarım ve Teknoloji 2022; 10(4): 1098 doi: 10.29109/gujsc.1201819
|
| 47 |
Gonca Kara Gedik, Farise Yilmaz. Is there any improvement in clinical staging with 18F-FDG PET/CT compared to surgical staging in cases of lung cancer?. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2019; 38(6): 348 doi: 10.1016/j.remnie.2019.05.007
|
| 48 |
Yue-Hua Zhang, Yuquan Lu, Hong Lu, Yue-Min Zhou. Development of a Survival Prognostic Model for Non-small Cell Lung Cancer. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00362
|
| 49 |
Haiming Huang, Jialin Du, Bo Jin, Lu Pang, Nan Duan, Chenwei Huang, Jiayin Hou, Wei Yu, Han Hao, Haixia Li. Combination of Urine Exosomal mRNAs and lncRNAs as Novel Diagnostic Biomarkers for Bladder Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.667212
|
| 50 |
Yuan Qiu, Liping Liu, Haihong Yang, Hanzhang Chen, Qiuhua Deng, Dakai Xiao, Yongping Lin, Changbin Zhu, Weiwei Li, Di Shao, Wenxi Jiang, Kui Wu, Jianxing He. Integrating Histologic and Genomic Characteristics to Predict Tumor Mutation Burden of Early-Stage Non-Small-Cell Lung Cancer. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.608989
|
| 51 |
Yue-Hua Zhang, Yuquan Lu, Hong Lu, Meng-Wei Zhang, Yue-Min Zhou, Xiang-Lei Li. Pretreatment Hemoglobin Level Is an Independent Prognostic Factor in Patients with Lung Adenocarcinoma. Canadian Respiratory Journal 2018; 2018: 1 doi: 10.1155/2018/6328127
|
| 52 |
Yu-Sen Huang, Jenny Ling-Yu Chen, Hsin-Ming Chen, Li-Hao Yeh, Jin-Yuan Shih, Ruoh-Fang Yen, Yeun-Chung Chang. Assessing tumor angiogenesis using dynamic contrast-enhanced integrated magnetic resonance-positron emission tomography in patients with non-small-cell lung cancer. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08064-4
|
| 53 |
Philipp E. Geyer, Sebastian Porsdam Mann, Peter V. Treit, Matthias Mann. Plasma Proteomes Can Be Reidentifiable and Potentially Contain Personally Sensitive and Incidental Findings. Molecular & Cellular Proteomics 2021; 20: 100035 doi: 10.1074/mcp.RA120.002359
|
| 54 |
Ashish K. Jain, Vishal K. Chitikeshi, Pritha Nayyar, Nitin Dayal, Anuja Anand. Granulomatous reaction in a patient with lung cancer: should we treat it?. Breathe 2018; 14(3): e94 doi: 10.1183/20734735.014617
|
| 55 |
Lei Lyu. Lung Cancer Diagnosis Based on Convolutional Neural Networks Ensemble Model. 2021 2nd International Seminar on Artificial Intelligence, Networking and Information Technology (AINIT) 2021; : 360 doi: 10.1109/AINIT54228.2021.00077
|
| 56 |
Lili Yuan, Lin An, Yandong Zhu, Chongling Duan, Weixiang Kong, Pei Jiang, Qing-Qing Yu. Machine Learning in Diagnosis and Prognosis of Lung Cancer by PET-CT. Cancer Management and Research 2024; : 361 doi: 10.2147/CMAR.S451871
|
| 57 |
Francesco Petrella, Stefania Rizzo, Ilaria Attili, Antonio Passaro, Thomas Zilli, Francesco Martucci, Luca Bonomo, Filippo Del Grande, Monica Casiraghi, Filippo De Marinis, Lorenzo Spaggiari. Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options. Current Oncology 2023; 30(3): 3160 doi: 10.3390/curroncol30030239
|
| 58 |
Pengyu Zhang, Yingxin Ruan, Jun Xiao, Fangfang Chen, Xuejun Zhang. Association of serum follistatin levels with histological types and progression of tumor in human lung cancer. Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0664-2
|
| 59 |
Jiannan Liu, Ying Liu, Wenjing Gong, Xiangshuo Kong, Congcong Wang, Shuhua Wang, Aina Liu. Prognostic value of insulin‑like growth factor 2 mRNA‑binding protein 3 and vascular endothelial growth factor‑A in patients with primary non‑small‑cell lung cancer. Oncology Letters 2019; doi: 10.3892/ol.2019.10835
|